P682: NEMTABRUTINIB (MK-1026), A NON-COVALENT INHIBITOR OF WILD-TYPE AND C481S MUTATED BRUTON TYROSINE KINASE FOR B-CELL MALIGNANCIES: EFFICACY AND SAFETY OF THE PHASE 2 DOSE-EXPANSION BELLWAVE-001 STUDY
| Published in: | HemaSphere |
|---|---|
| Main Authors: | J. Woyach, I. W. Flinn, F. T. Awan, H. Eradat, D. Brander, M. Tees, S. A. Parikh, T. Phillips, W. Wang, N. M. Reddy, M. Z. Farooqui, J. C. Byrd, D. M. Stephens |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000845612.25766.0c |
Similar Items
P628: UPDATED ANALYSIS OF BELLWAVE-001: A PHASE 1/2 OPEN-LABEL DOSE-EXPANSION STUDY OF THE EFFICACY AND SAFETY OF NEMTABRUTINIB FOR THE TREATMENT OF B-CELL MALIGNANCIES
by: Jennifer Woyach, et al.
Published: (2023-08-01)
by: Jennifer Woyach, et al.
Published: (2023-08-01)
EFFICACY AND SAFETY OF NEMTABRUTINIB VERSUS CHEMOIMMUNOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA WITHOUT TUMOR PROTEIN 53 ABERRATIONS: THE OPEN-LABEL, RANDOMIZED, PHASE 3 BELLWAVE-008 STUDY
by: G Perini, et al.
Published: (2023-10-01)
by: G Perini, et al.
Published: (2023-10-01)
Combined cellular and biochemical profiling of Bruton’s tyrosine kinase inhibitor nemtabrutinib reveals potential application in MAPK-driven cancers
by: Daphne J. F. Kluitmans, et al.
Published: (2025-10-01)
by: Daphne J. F. Kluitmans, et al.
Published: (2025-10-01)
ZYBT1, a potent, irreversible Bruton’s Tyrosine Kinase (BTK) inhibitor that inhibits the C481S BTK with profound efficacy against arthritis and cancer
by: Krishnarup Ghoshdastidar, et al.
Published: (2020-08-01)
by: Krishnarup Ghoshdastidar, et al.
Published: (2020-08-01)
P481: Withdrawn
Published: (2023-01-01)
Published: (2023-01-01)
Pengaruh Penggunaan Yea-Sacc®1026 Terhadap Performans Sapi Potong
by: Rahmat Hidayat, et al.
Published: (2013-06-01)
by: Rahmat Hidayat, et al.
Published: (2013-06-01)
Genetic analysis of the CDI pathway from Burkholderia pseudomallei 1026b.
by: Sanna Koskiniemi, et al.
Published: (2015-01-01)
by: Sanna Koskiniemi, et al.
Published: (2015-01-01)
P1026: COMPARATIVE GENOMIC PROFILING OF MYELOPROLIFERATIVE NEOPLASMS PRESENTING WITH AND WITHOUT SPLANCHNIC VEIN THROMBOSIS
by: M. Garrote, et al.
Published: (2022-06-01)
by: M. Garrote, et al.
Published: (2022-06-01)
Yea-Sacc1026 Influence on Some Biophysical and Digestive Parameters of the Ruminal Fluid
by: Iuliana Crețescu, et al.
Published: (2023-10-01)
by: Iuliana Crețescu, et al.
Published: (2023-10-01)
“¿Cómo lees?"(Lc 10,26). Una pregunta a Michael Theobald
by: Andrés Francisco Di Ció
Published: (2019-05-01)
by: Andrés Francisco Di Ció
Published: (2019-05-01)
Tyr(682) in the intracellular domain of APP regulates amyloidogenic APP processing in vivo.
by: Alessia P M Barbagallo, et al.
Published: (2010-11-01)
by: Alessia P M Barbagallo, et al.
Published: (2010-11-01)
Coil embolization in 481 ruptured intracranial aneurysms: angiographic and clinical results
by: Hasan Dinç,, et al.
Published: (2013-05-01)
by: Hasan Dinç,, et al.
Published: (2013-05-01)
موقف الكنيسة من حكم كلوفيس (481-511)
by: Mohammed abood mohosh, et al.
Published: (2024-06-01)
by: Mohammed abood mohosh, et al.
Published: (2024-06-01)
HEMOSTATIC ALTERATIONS DURING BRUTON KINASE INHIBITORS TREATMENT
by: M. Carpenedo
Published: (2025-10-01)
by: M. Carpenedo
Published: (2025-10-01)
P682: ACMG ACT Sheets and Algorithms: Update process, development, and utilization
by: Molly Caisse, et al.
Published: (2023-01-01)
by: Molly Caisse, et al.
Published: (2023-01-01)
Amniocentesis Results According to Risk Factors: A Result of 1026 Women With Advanced Maternal Age
by: Tuncay Yüce, et al.
Published: (2016-04-01)
by: Tuncay Yüce, et al.
Published: (2016-04-01)
CaMK II in Cardiovascular Diseases, Especially CaMK II-δ: Friends or Enemies
by: Tan YQ, et al.
Published: (2024-08-01)
by: Tan YQ, et al.
Published: (2024-08-01)
Targeting Bruton’s Tyrosine Kinase in Inflammatory and Autoimmune Pathologies
by: Stefan F. H. Neys, et al.
Published: (2021-06-01)
by: Stefan F. H. Neys, et al.
Published: (2021-06-01)
Role of Bruton's Tyrosine Kinase in B Cell Development
by: Alex Maas, et al.
Published: (2001-01-01)
by: Alex Maas, et al.
Published: (2001-01-01)
Recurrent purulent meningitis in a patient with Bruton's disease
by: G Kanra, et al.
Published: (1987-04-01)
by: G Kanra, et al.
Published: (1987-04-01)
481 Endoscopic third ventriculostomy versus ventriculoperitoneal shunting for treatment of hydrocephalus in patients with myelomeningocele
by: Sasidhar Karuparti, et al.
Published: (2025-04-01)
by: Sasidhar Karuparti, et al.
Published: (2025-04-01)
The Impact of Inulin and a Novel Synbiotic (Yeast Saccharomyces cerevisiae Strain 1026 and Inulin) on the Development and Functional State of the Gastrointestinal Canal of Calves
by: S. Jonova, et al.
Published: (2021-01-01)
by: S. Jonova, et al.
Published: (2021-01-01)
SG-APSIC1026: COVID-19 vaccine acceptance and hesitancy among primary healthcare workers in Singapore
by: Sky Wei Chee Koh, et al.
Published: (2023-02-01)
by: Sky Wei Chee Koh, et al.
Published: (2023-02-01)
1026 PIK3IP1/TrIP immune regulation on CD8+ T cells restricts anti-tumor immunity
by: Sean Robinson, et al.
Published: (2023-11-01)
by: Sean Robinson, et al.
Published: (2023-11-01)
Targeting Bruton’s Tyrosine Kinase in CLL
by: Inhye E. Ahn, et al.
Published: (2021-06-01)
by: Inhye E. Ahn, et al.
Published: (2021-06-01)
Civil Architecture in Zaragoza in The Era of sect kings 422-481 Ah
by: Latif K. Muhammad, et al.
Published: (2021-06-01)
by: Latif K. Muhammad, et al.
Published: (2021-06-01)
La cuota 481. Un modelo de engorde a corral
by: Enrique Roberto Rudi
Published: (2020-03-01)
by: Enrique Roberto Rudi
Published: (2020-03-01)
La cuota 481. Un modelo de engorde a corral
by: Enrique Roberto Rudi
Published: (2020-03-01)
by: Enrique Roberto Rudi
Published: (2020-03-01)
Physical and Biogeochemical Regionalization of the Southern Ocean and the CCAMLR Zone 48.1
by: Giovanni Testa, et al.
Published: (2021-03-01)
by: Giovanni Testa, et al.
Published: (2021-03-01)
481 Interactions between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome
by: Julia Tobacyk, et al.
Published: (2023-04-01)
by: Julia Tobacyk, et al.
Published: (2023-04-01)
Parto en 481 Primíparas por Encima de 25 años
by: Germán Velasco L.
Published: (1967-06-01)
by: Germán Velasco L.
Published: (1967-06-01)
Transient constrictive pericarditis in Bruton disease: a case report
by: S. V. Kruchinova, et al.
Published: (2024-06-01)
by: S. V. Kruchinova, et al.
Published: (2024-06-01)
Assessing the bioefficacy of Cyantraniliprole 10.26% OD against fruit borer and thrips on chilli under field condition
by: Amit Layek, et al.
Published: (2024-02-01)
by: Amit Layek, et al.
Published: (2024-02-01)
WCN24-682 VALIDATION OF ALBUMIN CREATININE RATIO POINT OF CARE DEVICES FOR COMMUNITY TESTING
by: Kathryn Griffiths, et al.
Published: (2024-04-01)
by: Kathryn Griffiths, et al.
Published: (2024-04-01)
Crucial roles of the protein kinases MK2 and MK3 in a mouse model of glomerulonephritis.
by: Adam J Guess, et al.
Published: (2013-01-01)
by: Adam J Guess, et al.
Published: (2013-01-01)
P1231: ZILOVERTAMAB VEDOTIN (MK-2140) FOR THE TREATMENT OF NON-HODGKIN LYMPHOMA: THE PHASE 1 DOSE ESCALATION AND COHORT EXPANSION WAVELINE-001 STUDY OF AN ANTI-ROR1 ANTIBODY-DRUG CONJUGATE
by: M. Wang, et al.
Published: (2022-06-01)
by: M. Wang, et al.
Published: (2022-06-01)
Vegetative skin lesions in patient with bruton's agammaglobulinemia
by: Cristian Fidanzi, et al.
Published: (2023-01-01)
by: Cristian Fidanzi, et al.
Published: (2023-01-01)
P1200: ZILOVERTAMAB VEDOTIN (MK-2140) IN RELAPSED OR REFRACTORY (R/R) NON-HODGKIN LYMPHOMA (NHL): UPDATED RESULTS FROM THE PHASE 1 WAVELINE-001 STUDY
by: Stephen Spurgeon, et al.
Published: (2023-08-01)
by: Stephen Spurgeon, et al.
Published: (2023-08-01)
1026 Infarct size determines infarct healing and ventricular remodeling in patients with successfully reperfused ST-elevation myocardial infarction
by: Rademakers Frank E, et al.
Published: (2008-10-01)
by: Rademakers Frank E, et al.
Published: (2008-10-01)
The impact of income growth on the nutritional structure of poverty-alleviated rural families: Empirical evidence from 1026 households in Ningxia
by: LI Yu, LI Tao
Published: (2023-10-01)
by: LI Yu, LI Tao
Published: (2023-10-01)
Similar Items
-
P628: UPDATED ANALYSIS OF BELLWAVE-001: A PHASE 1/2 OPEN-LABEL DOSE-EXPANSION STUDY OF THE EFFICACY AND SAFETY OF NEMTABRUTINIB FOR THE TREATMENT OF B-CELL MALIGNANCIES
by: Jennifer Woyach, et al.
Published: (2023-08-01) -
EFFICACY AND SAFETY OF NEMTABRUTINIB VERSUS CHEMOIMMUNOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA WITHOUT TUMOR PROTEIN 53 ABERRATIONS: THE OPEN-LABEL, RANDOMIZED, PHASE 3 BELLWAVE-008 STUDY
by: G Perini, et al.
Published: (2023-10-01) -
Combined cellular and biochemical profiling of Bruton’s tyrosine kinase inhibitor nemtabrutinib reveals potential application in MAPK-driven cancers
by: Daphne J. F. Kluitmans, et al.
Published: (2025-10-01) -
ZYBT1, a potent, irreversible Bruton’s Tyrosine Kinase (BTK) inhibitor that inhibits the C481S BTK with profound efficacy against arthritis and cancer
by: Krishnarup Ghoshdastidar, et al.
Published: (2020-08-01) -
P481: Withdrawn
Published: (2023-01-01)
